Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03856437 · ClinicalTrials.gov registry record · NA
A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination
A NA study, sponsored by University of Maryland, College Park.
- Completed
- Registry status
- NA
- Development phase
- 1,170
- Enrollment target
NCT03856437: Completed NA study, sponsored by University of Maryland, College Park.
NCT03856437 is a NA study that has completed, run by University of Maryland, College Park. The registered enrollment target is 1,170 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (17% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03856437, a NA study, has completed, sponsored by University of Maryland, College Park.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,170 participants
- Enrollment target
Study Summary
The goal of this study is to determine the effects of message framing (gain vs. loss) on African American parents' acceptance of the HPV vaccine and how such effects are moderated by parents' salient beliefs prior to message exposure. Participants are randomized into gain and loss conditions in which they view either gain-framed or loss-framed HPV vaccination messages. Key outcome variables include parents' attitudes and intentions toward vaccinating their children against HPV.
Primary Outcome
Attitudes toward HPV vaccination for children Scale range: 1-7 (higher score indicates more positive attitude) Subscales were averaged.
Interventions
- BEHAVIORAL HPV vaccination messages
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,170 participants |
| Start Date | 2021-01-22 |
| Est. Completion | 2022-04-15 |
| Phase | NA |
What the finished NCT03856437 record still lists
NCT03856437 is an interventional study that assigns participants to a tested intervention. Its 1,170 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (17% lower).
The record links to 0 conditions, and to 1 intervention - of which HPV vaccination messages is the first listed.
NCT03856437 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03856437 about?
NCT03856437 is a clinical study titled "A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination". The goal of this study is to determine the effects of message framing (gain vs. loss) on African American parents' acceptance of the HPV vaccine and how such effects are moderated by parents' salient beliefs prior to message exposure. Participants are randomized into gain and loss conditions in whic...
What is the current status of trial NCT03856437?
This trial is currently completed. It is a NA study. The enrollment target is 1,170 participants. The study started on 2021-01-22. Estimated completion is 2022-04-15.
What interventions are being tested in trial NCT03856437?
The interventions under investigation include: HPV vaccination messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT03856437?
This trial is sponsored by University of Maryland, College Park, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03856437's enrollment target sits among peer trials
1,170 90th of 2000 higher than 1,911 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06469788 · 1,170 participants · NA
Testimonials and Navigation in Rheumatology
- NCT04275557 · 1,174 participants
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas
- NCT07009509 · 1,166 participants · NA
Pilot Study of the YES-CAN! Program to Prevent Youth Nicotine Vaping
- NCT06133322 · 1,176 participants · NA
Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSED)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI